Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX0DGL
|
||||
Drug Name |
4-Methyl-2-(3-pyridin-3-yl-phenyl)-pentanoic acid cyanomethyl-amide
|
||||
Synonyms |
CHEMBL123592
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C19H21N3O
|
||||
Canonical SMILES |
CC(C)CC(C(=O)NCC#N)c1cccc(c1)c2cccnc2
|
||||
InChI |
InChI=1S/C19H21N3O/c1-14(2)11-18(19(23)22-10-8-20)16-6-3-5-15(12-16)17-7-4-9-21-13-17/h3-7,9,12-14,18H,10-11H2,1-2H3,(H,22,23)
|
||||
InChIKey |
IHQHRMDKNBEEEL-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.